The first report of institutional cancer registry in a center located in Medellín, Colombia

Primer reporte del registro institucional de pacientes con cáncer, en un centro de Medellín, Colombia

Main Article Content

Beatriz Elena Preciado Franco
Diego Moran Ortiz
Camila Lema
Maria Jose Fernandez Turizo
Esteban Calle Correa
Mateo Pineda Álvarez
Juan Pablo Ospina Sánchez
Laura Elisa Villegas Sierra
Mauricio Luján Piedrahita
Jorge A. Egurrola-Pedraza
Mauricio Lema
Abstract

Purpose: This is the first report of an institutional-based cancer registry in Clínica de Oncología Astorga, in Medellín, Colombia. It was created to produce local information on socio-demographic and clinical characteristics, therapies, and survival outcomes of patients with the most frequent tumors in the institution.  Methods: All consecutive patients with cancers of the breast (BC), prostate (PC), lung (LC), colorectal (CRC), ovarian, stomach, pancreas, cervical, and melanoma, diagnosed after January 1/2019, and treated at the institution were included. A description of the entire cohort and of the five most frequent tumor types was performed. Kaplan-Meier curves for each tumor stage were used to estimate overall survival (OS) and progression-free survival (PFS). Statistical analysis was performed using SPSS v22. Results: Data from 729 patients were analyzed. The median follow-up was 12.0 months (IQR 5.8-18.1). The main diagnoses were BC, PC, CRC, LC, and cervical cancer in 57.2%, 10.2%, 8.0%, 7.7%, and 5.8% of patients, respectively. The most frequent stage at diagnosis was: stage II for BC (36.6%) and PC (35.1%), stage III for CRC (62.1%) and cervical cancer (50.0%), and stage IV for LC (62.5%).  In BC cases, the median PFS for stage IV patients was 10.8 months (95%CI: 8.7-13.0). In LC cases, median PFS and OS for stage IV were 5.6 months (95%CI: 4.1-7.0), and 6.8 months (95%CI: 2.5-11.1), respectively.  Conclusion: Even though follow-up is short in this first report, PFS for metastatic BC and PFS and OS for metastatic LC reflect the aggressive nature of these conditions in Colombia.

Keywords

Downloads

Download data is not yet available.

Article Details

Author Biographies (SEE)

Beatriz Elena Preciado Franco, Clínica de Oncología Astorga, Medellín, Colombia.

Médica, Especialista en Ginecobstetricia.

Diego Moran Ortiz, Clínica de Oncología Astorga, Medellín, Colombia.

Médico, Especialista en Oncología.

Camila Lema, Clínica de Oncología Astorga, Medellín, Colombia.

Médica, Especialista en Epidemiología, MSc en Investigación Biomédica Traslacional.

Maria Jose Fernandez Turizo, Clínica de Oncología Astorga, Medellín, Colombia.

Médica.

Esteban Calle Correa, Clínica de Oncología Astorga, Medellín, Colombia.

Médico.

Mateo Pineda Álvarez, Clínica de Oncología Astorga, Medellín, Colombia.

Médico.

Juan Pablo Ospina Sánchez, Clínica de Oncología Astorga, Medellín, Colombia.

Médico.

Laura Elisa Villegas Sierra, Clínica de Oncología Astorga, Medellín, Colombia.

Médica.

Mauricio Luján Piedrahita, Clínica de Oncología Astorga, Medellín, Colombia.

Médico, Especialista en Oncología Clínica.

Jorge A. Egurrola-Pedraza, Clínica de Oncología Astorga, Medellín, Colombia.

Médico, MSc en Epidemiología.

Mauricio Lema, Clínica de Oncología Astorga, Medellín, Colombia.

Médico, Especialista en Hemato-Oncología

References

Valsecchi MG, Steliarova-Foucher E. Cancer registration in developing countries: luxury or necessity Lancet Oncol. [Internet]. 2008;9(2):159–67. Available from: https://doi.org/10.1016/S1470-2045(08)70028-7

World Health Organization (WHO). GLOBOCAN, International Agency for Research on Cancer (IARC).GLOBOCAN [Internet]. 2020: New Global Cancer Data [Internet]. 2020. Available from: https://www.uicc.org/news/globocan-2020-new-global-cancer-data#:text=IARC released on 14th December,million cancer deaths in 2020.

Parkin DM. The role of cancer registries in cancer control. Int J Clin Oncol. [Internet]. 2008;13(2):102–11. Available from: https://doi.org/10.1007/s10147-008-0762-6

Bravo LE, García LS, Collazos P, Carrascal E, Ramírez O, Collazos T, et al. Reliable information for cancer control in Cali, Colombia. Colomb Med. [Internet]. 2018;49(1):23–34. Available from: https://doi.org/10.25100/cm.v49i1.3689

Pérez CJU, Gómez SES, Sánchez CMH. Cancer incidence and mortality in Bucaramanga, Colombia. 2008-2012. Colomb Med. [Internet]. 2018;49(1):73–80. Available from: https://doi.org/10.25100/cm.v49i1.3632

Yépez MC, Jurado DM, Bravo LM, Bravo LE. Trends in cancer incidence, and mortality in pasto, Colombia. 15 years experience. Colomb Med. [Internet]. 2018;49(1):42–54. Available from: https://doi.org/10.25100/cm.v49i1.3616.

Aseguramiento - Georeferenciado. Así Vamos en Salud - indicadores en salud normatividad derechos [Internet]. 2022. Available from: https://www.asivamosensalud.org/indicadores/aseguramiento/aseguramiento-georeferenciado

Egurrola-Pedraza JA, Gómez-Wolff LR, Ossa-Gómez CA, Sánchez-Jiménez V, Herazo-Maya F, García-García HI. Survival difference due to types of health coverage in breast cancer patients treated at a specialized cancer center in Medellín, Colombia. Cad Saude Publica. [Internet] 2018;34(12). Available from: https://doi.org/10.1590/0102-311X00114117

Villarreal-Garza, C; Aguila, C; Magallanes-Hoyos, M; Mohar ABE. Breast Cancer in Young Women in Latin America : An Unmet , Growing need. The oncologist. [Internet] 18(12), 1298–1306. Available from: https://doi.org/10.1634/theoncologist.2013-0321

Montoya Restrepo M, Barcenas C, Gómez Wolf R, Cock Rada A, Castaño Vasquez M, García García H. Supervivencia de mujeres jóvenes con cáncer de mama en el Instituto de Cancerología Las Américas entre 2007 y 2016. Rev Colomb Hematol y Oncol. [Internet] 2020;7(2):26–32. Available from: https://doi.org/10.51643/RevColHemOnc

Pardo C, de Vríes E. Breast and cervical cancer survival at Instituo Nacional de Cancerología, Colombia. Colomb Med. [Internet] 2018;49(1):102–8. Available from: https://doi.org/10.25100/cm.v49i1.2840.

Hernández Vargas JA, Ramírez Barbosa PX, Gil Quijano AM, Valbuena AM, Acuña L, González JA. Patterns of breast, prostate and cervical cancer incidence and mortality in Colombia: an administrative registry data analysis. BMC Cancer. [Internet] 2020;20(1):1–9. Available from: https://doi.org/10.1186/s12885-020-07611-9

Campo-Sánchez SM, Camargo-Trillos J, Calle-Ramírez JA, Gómez-Wolff LR, Sánchez-Patiño LA, García-García HI. Colorectal cancer survival at an oncologic center in Colombia. A historic cohort study. Rev Gastroenterol Mex. [Internet] 2019;84(2):174–84. Available from: https://doi.org/10.1016/j.rgmx.2018.04.002

Fondo Colombiano de Enfermedades de Ato Costo. Situación del cáncer en la población adulta atendida en el SGSSS de Colombia [Internet] 2020. 2021;1–396. Available from: https://cuentadealtocosto.org/site/wp-content/uploads/2021/11/CAC.Co_2021_11_3_Libro_Sit_cancer2020_v5.pdf

Arias-Ortiz NE, de Vries E. Health inequities and cancer survival in Manizales, Colombia: A population-based study. Colomb Med. [Internet] 2018;49(1):63–72. Available from: https://doi.org/10.25100/cm.v49i1.3629.

OJS System - Metabiblioteca |